Tempus AI (TEM) EV/EBITDA: History & Chart

Tempus AI, Inc. (TEM)TEMTempus AI, Inc.

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$7.43B	N/A	N/A	N/A	N/A
Oscar Health, Inc. (OSCR)vs ›	$8.01B	150.31x	101.21x	52.84x	52.84x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$8.85B	22.38x	21.07x	19.54x	21.78x
Hims & Hers Health, Inc. (HIMS)vs ›	$5.76B	76.49x	65.83x	318.16x	318.16x
Henry Schein, Inc. (HSIC)vs ›	$9.83B	12.86x	11.46x	11.87x	11.65x
Universal Health Services, Inc. (UHS)vs ›	$10.27B	5.72x	6.82x	8.17x	8.20x
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	N/A	32.35x	25.45x	22.17x
Molina Healthcare, Inc. (MOH)vs ›	$10.45B	19.93x	7.64x	9.04x	10.49x
Bio-Techne Corporation (TECH)vs ›	$11.29B	44.83x	41.06x	35.51x	38.54x
Charles River Laboratories International, Inc. (CRL)vs ›	$11.44B	17.76x	17.62x	16.06x	17.43x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

Tempus AI, Inc. (TEM)

$7.43B

N/A

Oscar Health, Inc. (OSCR)vs ›

$8.01B

150.31x

101.21x

52.84x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$8.85B

22.38x

21.07x

19.54x

21.78x

Hims & Hers Health, Inc. (HIMS)vs ›

$5.76B

76.49x

65.83x

318.16x

Henry Schein, Inc. (HSIC)vs ›

$9.83B

12.86x

11.46x

11.87x

11.65x

Universal Health Services, Inc. (UHS)vs ›

$10.27B

5.72x

6.82x

8.17x

8.20x

Walgreens Boots Alliance, Inc. (WBA)vs ›

$10.37B

N/A

32.35x

25.45x

22.17x

Molina Healthcare, Inc. (MOH)vs ›

$10.45B

19.93x

7.64x

9.04x

10.49x

Bio-Techne Corporation (TECH)vs ›

$11.29B

44.83x

41.06x

35.51x

38.54x

Charles River Laboratories International, Inc. (CRL)vs ›

$11.44B

17.76x

17.62x

16.06x

17.43x

EV/EBITDA Ratio: N/A

TEM EV/EBITDA Ratio Metrics

TEM Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

Related Metrics